Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Intro highlights steps to build credit with a secured card while avoiding debt, emphasizing payment discipline and utilization management.
22,663 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A SpaceX IPO could unlock funding for a bold, space-based data center vision. This deep dive explains what data cente...
The beauty health (skin) 2025 landscape is reshaping portfolios. This guide breaks down earnings signals, growth engi...
As AI budgets surge, a majority of CEOs are freezing hiring even as they push capital into AI. The tension between au...
In 2026, real estate agents are shifting from pure transactions to advisory roles, helping buyers navigate financing ...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
A major fund trimmed its ACI Worldwide position, nudging the stock to trail the S&P 500 by a noticeable gap. This sto...
When a high-profile investor shifts a crypto position, the market takes notice. mark cuban says sold most of his Bitc...
As PDD Holdings gears up for its (pdd) 2026 earnings call, investors should focus on growth sustainability, margin pr...
Gulf nations are pouring billions into overseas renewables as oil flows face disruption from tensions with Iran, shif...
The stock market is flirting with a milestone not seen in 155 years. This article explains what a stock market verge ...